Table 1.
Correlation between miR-29c expression and different clinical characteristics
| Patients with low miR-29c expression | Patients with high miR-29c expression | p | |
|---|---|---|---|
| Age | 0.165 | ||
| < 60 y | 27 (61.4%) | 20 (46.5%) | |
| ≥ 60 y | 17 (38.6%) | 23 (53.3%) | |
| Sex | 0.458 | ||
| Male | 27 (61.4%) | 23 (53.5%) | |
| Female | 17 (38.6%) | 20 (46.5%) | |
| ECOG performance status | 0.740 | ||
| 0 | 21 (47.7%) | 19 (44.2%) | |
| 1 | 23 (52.3%) | 24 (55.8%) | |
| Weight loss | 1.000 | ||
| ≤ 5% | 42 (95.5%) | 41 (95.3%) | |
| > 5% | 2 (4.5%) | 2 (4.7%) | |
| Smoking status | 0.137 | ||
| Smokers | 19 (43.2%) | 12 (27.9%) | |
| Nonsmokers | 25 (56.8%) | 31 (72.1%) | |
| Tumor stage | 0.324 | ||
| 1 | 3 (6.8%) | 7 (16.3%) | |
| 2 | 32 (72.7%) | 30 (69.8%) | |
| 3 | 9 (20.5%) | 6 (14.0%) | |
| Postoperative chemotherapy | 0.313 | ||
| Yes | 40 (90.9%) | 36 (83.7%) | |
| No | 4 (9.1%) | 7 (16.3%) | |
| Postoperative radiotherapy | 0.125 | ||
| Yes | 12 (27.3%) | 6 (14.0%) | |
| No | 32 (72.7%) | 37 (86.0%) |